A	B	C
1	Main
2		Brand Name
3		Generic Name	brivanib
4		Mechanism	VEGFR inhibitor, FGFR2?
5		Clinical Trials
6			Phase III HCC post-sorafenib n=414 versus placebo ("BRISK PS")
7			Failed in December 2011.
8
9			Phase III versus Sorafenib n=1050 ("BRISK FL")
10
11			Phase III TACE Adjuvant HCC versus placebo n=870 "BRISK TA"
12
13			Phase III HCC Asian patients post-sorafenib "BRISK APS" n=252
14
15			mCRC